McMaster, Pfizer Canada partner to foster health equity in vaccine science

McMaster University is partnering with Pfizer Canada on an initiative that will address critical gaps in health equity and vaccine development. Supported by a $500K investment from Pfizer Canada, McMaster’s Global Nexus will support training for emerging vaccinology scholars from equity-deserving groups. This initiative also aims to address gaps in knowledge related to the vaccination of vulnerable populations, develop accessible education material on vaccines, and work with community partners to ensure a safe learning environment for the funded scholars. “This grant from Pfizer Canada underscores our shared commitment to advancing health equity,” said Global Nexus Executive Director Matthew Miller. “Through Global Nexus, these talented young scientists are driving innovation and addressing research gaps to ensure vaccines protect all communities.”